Valion Bio, Inc.
SEC CIK 1787740 · VBIO · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Handley Michael K | Director · Chief Operating Officer | filed 2025 - 2026 |
| Bolton Sheryle | Director | filed 2021 - 2026 |
| Valauri Christina Rizopoulos | Director | filed 2024 - 2026 |
| Ernst Jennifer | Director · Chief Executive Officer | filed 2021 - 2025 |
| Zikria Dean | Director | filed 2021 - 2025 |
| Drexler Karen | Director | filed 2021 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wolf Lisa G | Interim CFO | filed 2024 - 2026 |
| Lackey Melinda | General Counsel & SVP of Legal | filed 2026 - 2026 |
| Gurfein Blake | Chief Scientific Officer | filed 2021 - 2024 |
| Bambach Kimberly Ann | Interim CFO | filed 2023 - 2024 |
| Sabia Ryan | VP of Sales and Operations | filed 2021 - 2023 |
| Cai Veronica | Chief Financial Officer | filed 2022 - 2022 |
| Benz Briana | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.